Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis

被引:35
作者
Rocchi, Valeria [1 ]
Puxeddu, Ilaria [1 ]
Cataldo, Giuseppe [1 ]
Del Corso, Isabella [1 ]
Tavoni, Antonio [1 ]
Bazzichi, Laura [2 ]
Bombardieri, Stefano [2 ]
Migliorini, Paola [1 ]
机构
[1] Univ Pisa, Dept Clin & Expt Med, Clin Immunol & Allergy Unit, I-56126 Pisa, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Rheumatol Unit, I-56126 Pisa, Italy
关键词
RHEUMATOID-ARTHRITIS; IN-VITRO;
D O I
10.1093/rheumatology/keu181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1527 / 1529
页数:3
相关论文
共 10 条
[1]   Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review [J].
Al-Shakarchi, Israa ;
Gullick, Nicola J. ;
Scott, David L. .
PATIENT PREFERENCE AND ADHERENCE, 2013, 7 :653-666
[2]   Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper [J].
Brockow, K. ;
Garvey, L. H. ;
Aberer, W. ;
Atanaskovic-Markovic, M. ;
Barbaud, A. ;
Bilo, M. B. ;
Bircher, A. ;
Blanca, M. ;
Bonadonna, B. ;
Campi, P. ;
Castro, E. ;
Cernadas, J. R. ;
Chiriac, A. M. ;
Demoly, P. ;
Grosber, M. ;
Gooi, J. ;
Lombardo, C. ;
Mertes, P. M. ;
Mosbech, H. ;
Nasser, S. ;
Pagani, M. ;
Ring, J. ;
Romano, A. ;
Scherer, K. ;
Schnyder, B. ;
Testi, S. ;
Torres, M. ;
Trautmann, A. ;
Terreehorst, I. .
ALLERGY, 2013, 68 (06) :702-712
[3]   The in vitro diagnosis of drug allergy: status and perspectives [J].
Ebo, D. G. ;
Leysen, J. ;
Mayorga, C. ;
Rozieres, A. ;
Knol, E. F. ;
Terreehorst, I. .
ALLERGY, 2011, 66 (10) :1275-1286
[4]   Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate [J].
Maini, R. N. ;
Taylor, P. C. ;
Szechinski, J. ;
Pavelka, K. ;
Broell, J. ;
Balint, G. ;
Emery, P. ;
Raemen, F. ;
Petersen, J. ;
Smolen, J. ;
Thomson, D. ;
Kishimoto, T. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2817-2829
[5]   Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab [J].
Matucci, A. ;
Pratesi, S. ;
Petroni, G. ;
Nencini, F. ;
Virgili, G. ;
Milla, M. ;
Maggi, E. ;
Vultaggio, A. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2013, 43 (06) :659-664
[6]   Tocilizumab-induced erythroderma [J].
Nakamura, Motonobu ;
Tokura, Yoshiki .
EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (03) :273-274
[7]   Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials [J].
Sieper, Joachim ;
Porter-Brown, Benjamin ;
Thompson, Liz ;
Harari, Olivier ;
Dougados, Maxime .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) :95-100
[8]   2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis [J].
Simons, F. Estelle R. ;
Ardusso, Ledit R. F. ;
Bilo, M. Beatrice ;
Dimov, Vesselin ;
Ebisawa, Motohiro ;
El-Gamal, Yehia M. ;
Ledford, Dennis K. ;
Lockey, Richard F. ;
Ring, Johannes ;
Sanchez-Borges, Mario ;
Senna, Gian Enrico ;
Sheikh, Aziz ;
Thong, Bernard Y. ;
Worm, Margitta .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 12 (04) :389-399
[9]   Subset Analysis of Patients Experiencing Clinical Events of a Potentially Immunogenic Nature in the Pivotal Clinical Trials of Tocilizumab for Rheumatoid Arthritis: Evaluation of an Antidrug Antibody ELISA Using Clinical Adverse Event-Driven Immunogenicity Testing [J].
Stubenrauch, Kay ;
Wessels, Uwe ;
Birnboeck, Herbert ;
Ramirez, Francisco ;
Jahreis, Angelika ;
Schleypen, Julia .
CLINICAL THERAPEUTICS, 2010, 32 (09) :1597-1609
[10]   Drug eruption induced by IL-6 receptor inhibitor tocilizumab [J].
Yoshiki, R. ;
Nakamura, M. ;
Tokura, Y. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (04) :495-496